|
|
|
This Week's Stories
|
Autonomous Vehicles / Regulation
Apollo Go's Wuhan Freeze Is the AV Safety Case Europe Needed
At 20:57 on March 31, at least 100 fully driverless robotaxis simultaneously stalled across Wuhan's roads and elevated expressways, trapping passengers for up to two hours with broken SOS systems. No one was hurt — but the incident exposed every hard question European regulators have been quietly deferring. Here is what European founders, insurers, and policymakers should take from it before their own frameworks lock in.
Read →
|
|
Consumer Hardware / Capital Markets
XREAL's IPO Shows Europe Is Already the Target Market
XREAL has filed for a Hong Kong IPO with over 70% of its revenue already coming from outside China. With Project Aura — its Android XR glasses built with Google — expected to launch in 2026, European XR founders are no longer watching a distant threat. It is already on their doorstep, capitalised and backed by one of the world's most powerful tech ecosystems.
Read →
|
|
|
Funding Spotlight
|
airobotics
Xinghai Tu's Series B Signals Embodied AI Is Entering the Productivity Era
Beijing-based Xinghai Tu has closed a 1 billion yuan (~$140 million) Series B, pushing its total raise to nearly 3 billion yuan (~$420 million) and its valuation into the tens of billions. The round — oversubscribed by five existing investors — marks a pivotal shift from developer tooling toward industrial-scale deployment in manufacturing, logistics, and commercial services.
Read full story →
|
|
|
All Funding Rounds This Week
| Company |
Stage |
Sector |
Amount |
|
Anhui Province New Energy Entrepreneurship Investment Co., Ltd.
|
Strategic |
energy
|
$1.1B |
|
Moonshot AI
Hong Kong
|
Pre-IPO |
ai
|
$1.0B |
|
Guangzhou Port Group Co., Ltd.
Guangzhou
|
Strategic |
ecommerce
|
$383M |
|
EnerVenue
Changzhou
|
Series B |
energy
|
$300M |
|
Xinghai Graph
|
Series B |
ai
|
$290M |
|
Hefei Jingyi Integrated Circuit Co., Ltd.
Hefei
|
Strategic |
hardware
|
$290M |
|
Kunlun Tech
|
Strategic |
ai
|
$203M |
|
Yuansi Biopeptide
|
Series B |
biotech
|
$150M |
|
Bose Quantum
|
Series B |
—
|
$145M |
|
EPG
|
Series B |
ai
|
$100M |
|
Faao
|
Series C |
—
|
$100M |
|
Pinnacle Medicines
Shanghai
|
Series B |
biotech
|
$89M |
|
Shize Biology
|
Series C |
biotech
|
$73M |
|
QL Biopharm
|
Series C |
biotech
|
$72M |
|
Wiyuan Synthesis
|
Series A |
ai
|
$43M |
|
MicroCyto
|
Series A |
biotech
|
$43M |
|
Wei Yuan Synthesis
|
Series B |
ai
|
$43M |
|
StoReel
|
Series A |
ai
|
$34M |
|
Xuntù Technology
|
Series A |
ai
|
$29M |
|
AstronStone
|
Pre-A |
spacetech
|
$29M |
|
Mindsight Brain-Computer Interface
|
Angel |
biotech
|
$22M |
|
Aoyι Technology
|
Series C |
—
|
$22M |
|
Aoyi Technology
|
Series C |
—
|
$22M |
|
Zero Gravity Aircraft Industry
|
Pre-A |
ev
|
$22M |
|
OYMotion
|
Series C |
ai
|
$22M |
|
RoboParty
Shanghai
|
Angel |
ai
|
$20M |
|
Guangxiang Technology
|
Angel |
robotics
|
$14M |
|
Cellgenes
Shenzhen
|
Pre-A |
biotech
|
$14M |
|
Rongsu
|
Series A |
manufacturing
|
$14M |
|
Kunwei
Shenzhen
|
Series B |
robotics
|
$14M |
|
|
You're receiving this from chinatechsignals.com
Follow on X
·
Unsubscribe
·
View in browser
·
Not investment advice.
|
|